Analysts at StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a “sell” rating on the stock.
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $35.00 price objective on shares of SenesTech in a research report on Tuesday, May 14th.
Read Our Latest Analysis on SenesTech
SenesTech Trading Down 2.7 %
SenesTech (NASDAQ:SNES – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($3.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($3.20) by $0.12. SenesTech had a negative net margin of 464.09% and a negative return on equity of 155.19%. The company had revenue of $0.46 million during the quarter, compared to the consensus estimate of $0.49 million. During the same quarter last year, the company earned ($84.03) earnings per share. Analysts forecast that SenesTech will post -11 EPS for the current year.
Institutional Trading of SenesTech
An institutional investor recently bought a new position in SenesTech stock. McAdam LLC acquired a new stake in SenesTech, Inc. (NASDAQ:SNES – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned about 1.25% of SenesTech as of its most recent SEC filing. 5.19% of the stock is currently owned by institutional investors.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Read More
- Five stocks we like better than SenesTech
- There Are Different Types of Stock To Invest In
- Brinker International’s Price Dip is an Appetizing Entry Point
- How to Calculate Options Profits
- 3 Stocks That Could Beat the September Blues
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.